MDMA alters immunity to infections of the peripheral and central nervous systems
MDMA alters immunity to infections of the peripheral and central nervous systems
批准号:
7251076
负责人:
KENNETH L BOST
金额:
$25.2万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-04-01 至 2011-03-31
关键词:
AddressAminesAnimal ModelAntiviral ResponseApplications GrantsAttentionBacterial MeningitisBehaviorCell surfaceCellsClinicalCommunicable DiseasesComplementDendritic CellsDiseaseDrug Delivery SystemsEvaluationExposure toFunctional disorderGoalsHuman Herpesvirus 4Immune responseImmunityIn VitroInfectionInfectious MononucleosisInflammatoryInflammatory ResponseInvestigationLearningLeukocytesLinkMediatingModelingMusNervous System PhysiologyNeuraxisNoseOralPeripheralPersonal SatisfactionPharmaceutical PreparationsPredispositionProbabilityProhibitRiskSocial BehaviorSocializationSymptomsTeenagersTissuesViralViral Load resultVirusVirus DiseasesVirus Latencyage groupchemokineclub drugclub drug abusecytokinedrug of abuseecstasyexperienceimmune functionin vivomacrophagemicrobialmicrobial diseasemouse modelpathogenreceptorresponseyoung adult
中文摘要
描述(由申请者提供):青少年和年轻人是最有可能滥用越来越多的被称为“俱乐部毒品”的化合物的年龄段。摇头丸,或3,4-亚甲基二氧基甲基苯丙胺(MDMA),是目前最受欢迎的俱乐部滥用药物之一,我们刚刚开始了解这种药物对这些年轻人的中枢神经系统功能的有害影响。虽然我们怀疑一些疾病与俱乐部药物滥用之间存在联系,但还没有研究表明摇头丸是否会在微生物疾病期间对中枢神经系统或外周的免疫功能产生如此有害的影响。这有点令人惊讶,因为3,4-亚甲基二氧基甲基苯丙胺是年轻人最常滥用的药物之一。此外,摇头丸对中枢神经系统有主要影响,并会诱发非常社会行为,从而增加接触各种疾病的可能性。目前的建议将使用小鼠模型来研究3,4-亚甲基二氧基甲基苯丙胺如何改变保护性宿主对病毒感染的反应。具体地说,这项提案将调查3,4-亚甲基二氧基甲基苯丙胺在体内或体外暴露这种滥用药物后调节白细胞免疫反应的能力。药理学研究将使人们能够了解3,4-亚甲基二氧甲基苯丙胺发挥作用的机制。将特别注意示踪胺受体介导的机制的重要性。此外,3,4-亚甲基二氧基甲基苯丙胺及其代谢物对白细胞功能的直接影响将通过纯化细胞的培养来评估,随后将评估细胞因子和趋化因子的分泌以及细胞表面分子的表达。将对感染病毒的小鼠的组织进行补充性研究。这些研究将确定俱乐部药物摇头丸调节感染后炎症反应的机制,并首次将摇头丸的使用与年轻人疾病的恶化联系起来。
英文摘要
DESCRIPTION (provided by applicant): Teenagers and young adults are the age group most likely to abuse a growing list of compounds known as "club drugs". Ecstasy, or 3,4 methylenedioxymethamphetamine (MDMA), is currently one of the most popular club drugs of abuse, and we are just beginning to learn about the deleterious effects this drug can have on central nervous system function of these young adults. While we suspect there is a link between some diseases and club drug abuse, there have been no studies to investigate whether Ecstasy might have such a deleterious effect on immune function within the central nervous system or in the periphery during microbial diseases. This is somewhat surprising, since 3,4- methylenedioxymethamphetamine is one of the most commonly abused drugs by young adults. Furthermore, Ecstasy has its primary effects on the central nervous system and can induce the very social behaviors that would increase the likelihood of exposure to various diseases. The present proposal will use mouse models to investigate how 3,4-methylenedioxymethamphetamine can alter the protective host response to a viral infection. Specifically, this proposal will investigate the ability of 3,4-methylenedioxymethamphetamine to modulate the immune response of leukocytes following in vivo or in vitro exposure of this drug of abuse. Pharmacological studies will allow an understanding of the mechanims by which 3,4-methylenedioxymethamphetamine might exert its effects. Particular attention will be given to the importance of trace amine receptor-mediated mechanisms. In addition, the direct effects of 3,4-methylenedioxymethamphetamine and its metabolites on leukocyte function will be assessed using cultures of purified cells followed by an evaluation of cytokine and chemokine secretion and expression of cell surface molecules. Complementary studies will be performed on tissues from mice with a viral infection. These studies will define mechanisms by which the club drug, Ecstasy, can modulate inflammatory responses following infection, and represent the first effort to link the use of Ecstasy with exacerbated diseases of young adults.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Platform for practical delivery of oral autoantigens as co-therapies for neurolog
-
批准号:8640510
-
项目类别:
-
资助金额:$27.6万
-
财政年份:2014
-
负责人:KENNETH L BOST
-
依托单位:
Induced Autoantigen Expression Exacerbates EAE
-
批准号:8013914
-
项目类别:
-
资助金额:$21.17万
-
财政年份:2010
-
负责人:KENNETH L BOST
-
依托单位:
Induced Autoantigen Expression Exacerbates EAE
-
批准号:7779144
-
项目类别:
-
资助金额:$18.0万
-
财政年份:2010
-
负责人:KENNETH L BOST
-
依托单位:
MDMA alters immunity to infections of the peripheral and central nervous systems
-
批准号:7389648
-
项目类别:
-
资助金额:$24.7万
-
财政年份:2007
-
负责人:KENNETH L BOST
-
依托单位:
MDMA alters immunity to infections of the peripheral and central nervous systems
-
批准号:7798952
-
项目类别:
-
资助金额:$24.45万
-
财政年份:2007
-
负责人:KENNETH L BOST
-
依托单位:
MDMA alters immunity to infections of the peripheral and central nervous systems
-
批准号:7608715
-
项目类别:
-
资助金额:$24.7万
-
财政年份:2007
-
负责人:KENNETH L BOST
-
依托单位:
Edible adjuvant expressed in transgenic soybeans
-
批准号:6814707
-
项目类别:
-
资助金额:$6.63万
-
财政年份:2004
-
负责人:KENNETH L BOST
-
依托单位:
An edible adjuvant expressed in transgenic soybeans
-
批准号:6953761
-
项目类别:
-
资助金额:$6.63万
-
财政年份:2004
-
负责人:KENNETH L BOST
-
依托单位:
Limited IL-12B2 receptor expression during salmonellosis
-
批准号:6632243
-
项目类别:
-
资助金额:$16.25万
-
财政年份:2001
-
负责人:KENNETH L BOST
-
依托单位:
Limited IL-12B2 receptor expression during salmonellosis
-
批准号:6511235
-
项目类别:
-
资助金额:$16.25万
-
财政年份:2001
-
负责人:KENNETH L BOST
-
依托单位:
Limited IL-12B2 receptor expression during salmonellosis
-
批准号:6400720
-
项目类别:
-
资助金额:$16.25万
-
财政年份:2001
-
负责人:KENNETH L BOST
-
依托单位:
EXACERBATION OF EAE BY MURINE GAMMAHERPESVIRUS, MHV-68
-
批准号:6540288
-
项目类别:
-
资助金额:$19.79万
-
财政年份:2000
-
负责人:KENNETH L BOST
-
依托单位:
EXACERBATION OF EAE BY MURINE GAMMAHERPESVIRUS, MHV-68
-
批准号:6465478
-
项目类别:
-
资助金额:$6.99万
-
财政年份:2000
-
负责人:KENNETH L BOST
-
依托单位:
EXACERBATION OF EAE BY MURINE GAMMAHERPESVIRUS, MHV-68
-
批准号:6394487
-
项目类别:
-
资助金额:$27.01万
-
财政年份:2000
-
负责人:KENNETH L BOST
-
依托单位:
EXACERBATION OF EAE BY MURINE GAMMAHERPESVIRUS, MHV-68
-
批准号:6165301
-
项目类别:
-
资助金额:$20.54万
-
财政年份:2000
-
负责人:KENNETH L BOST
-
依托单位:
MACROPHAGE ACTIVATION & SUBSTANCE P RECEPTOR EXPRESSION
-
批准号:2067925
-
项目类别:
-
资助金额:$13.65万
-
财政年份:1994
-
负责人:KENNETH L BOST
-
依托单位:
MACROPHAGE ACTIVATION & SUBSTANCE P RECEPTOR EXPRESSION
-
批准号:2067926
-
项目类别:
-
资助金额:$13.98万
-
财政年份:1994
-
负责人:KENNETH L BOST
-
依托单位:
MACROPHAGE ACTIVATION & SUBSTANCE P RECEPTOR EXPRESSION
-
批准号:6373276
-
项目类别:
-
资助金额:$20.01万
-
财政年份:1994
-
负责人:KENNETH L BOST
-
依托单位:
MACROPHAGE ACTIVATION & SUBSTANCE P RECEPTOR EXPRESSION
-
批准号:2067927
-
项目类别:
-
资助金额:$14.54万
-
财政年份:1994
-
负责人:KENNETH L BOST
-
依托单位:
MACROPHAGE ACTIVATION & SUBSTANCE P RECEPTOR EXPRESSION
-
批准号:2886762
-
项目类别:
-
资助金额:$18.86万
-
财政年份:1994
-
负责人:KENNETH L BOST
-
依托单位:
海外基金